1 Min Read
June 19 (Reuters) - Reneuron Group Plc
* FDA approves cryopreserved formulation of reneuron’s retinal stem cell therapy candidate Source text for Eikon: Further company coverage: (Reporting By London Bureau)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.